About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Gastro-oesophageal reflux
Helicobacter pylori
Infection
Inflammatory bowel disease
Irritable bowel syndrome
Liver, including hepatitis and cirrhosis
Motility and visceral sensation
Nausea and vomiting
Oesophagus
Pancreas and biliary tract
Peptic Ulceration
Small intestine
Stomach and duodenum
13 library items
in Oesophagus
Filter results by:
Date Published
2012 (0)
2011 (3)
2010 (0)
2009 (3)
2008 (1)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Gastroenterology (
remove
)
,
Oesophagus (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 13
Result page:
Previous
|
1
2
|
Next
1.
FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and potential increased risk of oesophageal cancer
Source:
FDA
,
Date published:
22/07/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Adverse Drug Reactions
|
Cancer: gastroenterological
|
Food &Drug Administration (FDA)
|
Oesophagus
NeLM
Area:
News
FDA communication
FDA MedWatch summary
2.
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Source:
Lancet Oncology
,
Date published:
17/06/2011
Category:
8.1 Cytotoxic drugs
|
Cancer: gastroenterological
|
Oesophagus
NeLM
Area:
News
Abstract
Comment
3.
A systematic review and meta-analysis of the treatment for Barrett's esophagus
Source:
DARE
,
Date published:
17/01/2011
Category:
1.3.1 H2-receptor antagonists
|
1.3.5 Proton pump inhibitors
|
Oesophagus
NeLM
Area:
Evidence
>
Disease Focused Reviews
DARE abstract
4.
Review: Barrett's Oesophagus
Source:
NEJM
,
Date published:
24/12/2009
Category:
1: Gastro-intestinal system
|
Oesophagus
NeLM
Area:
News
Abstract
5.
P&G launches campaign to improve compliance with osteoporosis treatment
Source:
PharmaTimes
,
Date published:
18/09/2009
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Adverse Drug Reactions
|
Community pharmacy
|
General Advice
|
Information provision
|
Oesophagus
|
Osteoporosis
|
Pharmaceutical Industry
NeLM
Area:
News
Link
Full Access Requires Registration with PharmaTimes
6.
NICE consults on scope for guideline on Barrett's oesophagus
Source:
NICE
,
Date published:
16/03/2009
Category:
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
|
Oesophagus
NeLM
Area:
News
Link
7.
Steroids in second degree caustic burns of the esophagus. A systematic pooled analysis of fifty years of human data: 1956-2006
Source:
DARE
,
Date published:
08/05/2008
Category:
6.3.2 Glucocorticoid therapy
|
Emergency Medicine
|
Oesophagus
|
Paediatrics
NeLM
Area:
Evidence
>
Disease Focused Reviews
DARE abstract
8.
Esomeprazole 20mg and 40mg tablets (Nexium®) - extension of current licence for the treatment of GORD to include patients from 12 years of age
Source:
Scottish Medicines Consortium
,
Date published:
12/06/2007
Category:
1.3.5 Proton pump inhibitors
|
Adolescents (11-18 years)
|
Drugs in paediatrics
|
Gastro-oesophageal reflux
|
Oesophagus
|
Scottish Medicines Consortium
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
9.
SMC accepts esomeprazole (Nexium) for restricted use in patients aged 12-17 years of age
Source:
SMC
,
Date published:
12/06/2007
Category:
1.3.5 Proton pump inhibitors
|
Adolescents (11-18 years)
|
Drugs in paediatrics
|
Gastro-oesophageal reflux
|
Oesophagus
|
Scottish Medicines Consortium
NeLM
Area:
News
Link
10.
Eosinophilic esophagitis in adults: a systematic review
Source:
DARE
,
Date published:
05/03/2007
Category:
1.3.5 Proton pump inhibitors
|
Oesophagus
NeLM
Area:
Evidence
>
Disease Focused Reviews
DARE abstract
Results 1 - 10 of 13
Result page:
Previous
|
1
2
|
Next
